Thu, Jan 04, 2024
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application for Dapagliflozin and Saxagliptin tablets, the Mumbai-based drug maker said in a regulatory filing.
More >
Fri, Sep 30, 2022
Lupin share price on Friday jumped over 4 per cent as it received the US FDA nod for manufacturing a new drug to treat overactive bladder at the company's facility in Nagpur.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
